Bipartisan Lawmakers Grill FDA on Generics, Plan B; Eschenbach Offers no Timelines

Drug Industry Daily
KEYWORDS budget / Capitol Hill

A bipartisan group of House lawmakers used a Feb. 16 hearing on the FDA’s fiscal 2007 budget as an opportunity to blast the agency’s top official on several fronts, including delays in approving the Plan B emergency contraceptive and a growing backlog of generic drug reviews.

To View This Article:


Subscribe To Drug Industry Daily